Page 3 - Les meilleurs doctors traitant la maladie suivante : Glioblastome - TOP -83 des médecins

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Une oncologue formée au Sloan-Kettering Cancer Center de New York, de renommée mondiale. Le Dr Jablonski-Perec met cette expertise approfondie au service de son travail au centre médical Hadassah.

• Professeure au département d'oncologie de l'Université hébraïque
• Directrice du centre de traitement du cancer du sein depuis 1998
• Titulaire d'un doctorat en sciences médicales
• Membre de plusieurs communautés internationales de lutte contre le cancer
• Lauréate d'une bourse de la faculté de médecine d'Hadassah

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Le Dr Do Hyun Nam est réputé pour les chirurgies endoscopiques du cerveau et l'ablation de tumeurs au Samsung Medical Center – l'un des meilleurs hôpitaux de Corée du Sud.

• Se spécialiser en neurochirurgie pédiatrique et adulte
• Être expert dans le traitement des tumeurs cérébrales bénignes et malignes
• Pratiquer des procédures de radiochirurgie avancées

Le Dr Graus a dirigé le groupe d'experts qui a défini pour la première fois des critères de diagnostic stricts pour les syndromes neurologiques paranéoplasiques, une avancée majeure en neuro-oncologie.

• Doctorat en médecine (MD) et PhD de l'Universitat Autònoma de Barcelona
• Spécialisation (Fellowship) en neuro-oncologie au Memorial Sloan-Kettering Cancer Center
• Fondateur et ancien président de l'European Association of Neuro-Oncology
• Chercheur émérite à l'institut de recherche IDIBAPS
• Ancien chef du service de neurologie de l'Hospital Clínic Barcelona

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Directeur de l'unité de neurochirurgie expérimentale de San Raffaele, le professeur Mortini est spécialisé dans la chirurgie mini-invasive du cerveau et de la colonne vertébrale.

• Plus de 30 ans d'expérience en neurochirurgie
• Expert en neuronavigation et en neuromapping pour la précision
• Détenteur d'un brevet pour une méthode de régénération tissulaire
• Professeur invité à l'Université George Washington

Spécialisé en radio-oncologie avec une formation à l'Université de Marmara.

• Diplômé de la Faculté de médecine de l'Université de Marmara
• Avoir terminé la spécialisation en radio-oncologie
• Exercer à l'Hôpital Emsey

Le Dr Perez dirige des programmes d'enseignement à l'hôpital régional de Puerto Vallarta, garantissant des normes élevées en matière d'éducation médicale.

• Se spécialiser dans les procédures chirurgicales mini-invasives
• Être certifié en biomagnétisme par l'Institut Supérieur de Biomagnétisme
• Être qualifié dans divers traitements dermatologiques et esthétiques
• Être expérimenté dans la gestion des dossiers cliniques

Le professeur associé Dr Emrah Eraslan est spécialisé en oncologie médicale, particulièrement pour les cas de cancer complexes, et exerce actuellement à l'hôpital Koru d'Ankara.

• Certifié en oncologie médicale avec plus de 12 ans d'expérience
• Formé à l'hôpital de formation et de recherche en oncologie Dr Abdurrahman Yurtaslan d'Ankara
• Spécialisé dans les cancers du sein, de la prostate, du poumon et colorectal
• Chercheur publié contribuant aux progrès de l'oncologie